Northwind Pharmaceuticals

Excited to be the Premier Sponsor for Art for Beds!

GFC VanGennesaret Free Clinics was founded by Dr. James Trippi in 1988 to serve the medical needs of the homeless within Indianapolis.  Over the years, Gennesaret Free Clinics has expanded to provide healthcare to those most in need and thrived through the willingness, dedication and hard work of over 200 volunteer health care professionals and others from our community. Today, Gennesaret Free Clinics has medical clinics in one shelter, a church, a mobile medical van and clinic sites in two food pantries – all staffed by volunteers. Other programs of Gennesaret Free Clinics include a Dental and Wellness Clinic, a Women’s Health Initiative, Health Recovery Programs for homeless men and women who have been hospitalized and need a place to heal,a Vision Care Program, and the Jamie Blackwell Loveless Annual Flu Vaccine Clinic. Gennesaret Free Clinics – a community response to a community need, dedicated to healing.

One of Gennesaret’s primary fund raising activities is Art of Beds.  A event that brings GFC donors, volunteers, and staff together to celebrate the good work of this organization, raise money to continue its mission, and raise awareness of the major gaps in care that still exist within Indianapolis.  This year’s event is on April 17 at the Crane Bay Event Center in downtown Indianapolis.  For those that can’t attend, opportunities exist to support GFC by clicking this link.

Northwind Pharmaceuticals is proud to be this year’s Premier Sponsor of Art for Beds and we invite you to get involved in the GFC mission to serve those most in need in our city.

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading